An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling

QR Code

An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling

Background & Aims: Published estimates for the rate of progression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EAC) vary. We used simulation modeling to reconcile published data and more accurately estimate the incidence of EAC among people with BE. Methods: We calibrated th...

Full description

Bibliographic Details
Main Authors:	Kroep, S., Lansdorp_Vogelaar, Iris, Rubenstein, J., de Koning, H., Meester, R., Inadomi, J., van Ballegooijen, M.
Format:	Journal Article
Published:	W.B. Saunders Co. 2015
Online Access:	http://hdl.handle.net/20.500.11937/49933

Similar Items

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)

Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis
by: Kroep, S., et al.
Published: (2017)

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device
by: Heberle, C., et al.
Published: (2017)

Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, spain, and the Netherlands
by: Kroep, S., et al.
Published: (2014)

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)

Cost effectiveness of surveillance for GI cancers
by: Omidvari, A., et al.
Published: (2016)

Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
by: Kong, C., et al.
Published: (2014)

Calibrating Parameters for Microsimulation Disease Models
by: Van Der Steen, A., et al.
Published: (2015)

Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality
by: Etzioni, R., et al.
Published: (2013)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

Endoscopic multimodal imaging in Barrett's oesophagus
by: Mannath, Jayan
Published: (2013)

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)

Randomized factorial trial of esomeprazole and aspirin in Barrett’s oesophagus: the Aspirin and Esomeprazole Chemoprevention in Barrett’s metaplasia Trial (AspECT)
by: Jankowski, Janusz A.Z., et al.
Published: (2018)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Fecal occult blood testing when colonoscopy capacity is limited
by: Wilschut, J., et al.
Published: (2011)

MDM2 expression in the progression of Barrett’s oesophagus
by: Robinson, Leora, et al.
Published: (2018)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing
by: van der Vlugt, M., et al.
Published: (2017)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Kuala Lumpur International Book Fest: UMP Publisher among the 10 best university publishers
by: Muhammad Azli, Shukri
Published: (2013)

Utilization of surveillance after Polypectomy in the Medicare population - A cohort study
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2014)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)

Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6vtcfnsotil8279908duos3jsu